ISSUE HIGHLIGHTS
ISPOR Conferences
The Day in Pictures
ISPOR Conferences
HTA for Gene Therapies: Are Our Methods Fit for Purpose?
ISPOR Conferences
Poster Session Recap: Mental Health
ISPOR Conferences
Machine Learning Methods Session Draw Large Crowds at ISPOR 2022
ISPOR Conferences
Using Big Data to Unpack the Health Equity Considerations
ISPOR Conferences
Video: ISPOR in Action!
ISPOR Conferences
Poster Session Recap: Infectious Disease (Non-Vaccine)
ISPOR Conferences
Poster Session Recap: Rare and Orphan Diseases
ISPOR Conferences
Advances in the Development of Real-World Evidence
ISPOR Conferences
Defining and Operationalizing No-Value Care
ISPOR Conferences
Improving the Acceptability of RWE: What's New in 2022?
ISPOR Conferences
Emerging Methods in Economic Evaluations
ISPOR Conferences
Machine Learning in HEOR: Are We at the Final Frontier?
ISPOR Conferences
HEOR Studies in Medication Management
ISPOR Conferences
Poster Session Recap: Diabetes/Endocrine/Metabolic Disorders
ISPOR Conferences
Poster Session Recap: Low- and Middle-Income Countries
ISPOR Conferences
Opening Day Plenary Features Discussion on HTA on the Run
ISPOR Conferences
Video: ISPOR Introduces RWE Subprogram
ISPOR Conferences
Analytic Studies in Patient-Centered Research
ISPOR Conferences
Examining the Cost-Effectiveness in Oncology Studies
ISPOR Conferences
Capturing Humanistic Outcomes: A Vital Part of Therapeutic Management
ISPOR Conferences
Poster Session Recap: Real-World Evidence Studies
ISPOR Conferences
Poster Session Recap: Cardiovascular Disorders
COLUMNS
Latest News
Rethinking Value Assessment for Orphan Drugs
Dec 18, 2024
ISPOR Launches “HEOR Explained” Microsite
Dec 10, 2024